Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

ASCO news: polymeric CPT derivative assessed in phase I for toxicity and pharmacokinetics

May 25, 2000

Lipophilic camptothecin derivatives with favorable profile of activity, toxicity

May 25, 2000

AstraZeneca develops new treatments for cancer, rheumatoid arthritis, etc.

May 25, 2000

Oregon State U. researchers disclose curacin A derivatives with improved stability

May 25, 2000

TNP-470 delays gastric ulcer healing in rats

May 25, 2000

GTI-2040 phase I/II trial on target for completion by year-end

May 25, 2000

Proteasome inhibitor MG-132 endowed with antineoplastic activity

May 25, 2000

DDW presentations support efficacy of exisulind in FAP and related conditions

May 24, 2000

Inhibitors of cyclin-dependent kinases claimed by DuPont for cancer

May 24, 2000

Proteasome inhibitors and their use presented by Max Planck

May 24, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Sumitomo’s DSP-3456 exerts antidepressant-like effects
BioWorld Science
About one-third of patients with major depressive disorder (MDD) are treatment resistant. Ketamine is very effective in treatment-resistant depression, but it is...